Holly Fechner

Holly Fechner

Partner

Holly Fechner has two decades of legal, legislative and public policy experience in the public and private sectors.  Ms. Fechner has a broad-based practice handling legislative and regulatory matters for clients in areas including healthcare, tax, intellectual property, education, and employee benefits.  Drawing on her extensive congressional and private sector experience, Ms. Fechner offers clients comprehensive advocacy services, including strategic advice, substantive legal and regulatory expertise, and policy and message development.  She has a proven track record in assisting clients fulfill their government affairs goals.

Subscribe to all posts by Holly Fechner

Stronger patents dominate IP agenda in 115th Congress

Patents have been mainstay of the Judiciary Committee agenda in both chambers for more than a decade, but never before has the debate seemed so firmly focused on strengthening patent rights.  Significant patent bills are pending in both chambers, and the House and Senate Judiciary Committees have summoned Andrei Iancu, the new director of the … Continue Reading

Recent Developments in the Joint Select Committee on Solvency of Multiemployer Pension Plans

The solvency crisis bearing down on the multiemployer pension plan system has captured the attention of Capitol Hill.  Since March, the Joint Select Committee on Solvency of Multiemployer Pension Plans (the “Committee”) has held a series of hearings examining the multiemployer pension system.  Although it is unclear whether the bipartisan Committee ultimately will agree on … Continue Reading

Recent Developments at the USPTO

Change is afoot at the U.S. Patent and Trademark Office (USPTO).  Since Director Andrei Iancu took office in February and declared “creating a new pro-innovation, pro-IP dialogue” a top priority, the agency has experienced a flurry of activity.  Beyond the significant shift in its rhetoric on intellectual property, the USPTO has moved to “increase predictability … Continue Reading

Congressional Review Act Developments

In response to the unprecedented use of the Congressional Review Act (“CRA”) by the 115th Congress and the Trump Administration, the Center for Biological Diversity (“Center”), a nonprofit dedicated to wildlife conservation, filed a lawsuit in an Alaska federal court challenging the constitutionality of the Act. The CRA is a statute that requires federal agencies … Continue Reading

Use of the Congressional Review Act in the 115th Congress to Overturn Obama Administration Regulations

In just five short weeks, the 115th Congress will convene in Washington.  Now that Republicans control majorities in both houses and the White House, Republican leaders hope to use the Congressional Review Act (CRA) to overturn regulations issued by the Obama Administration over the past few months.  According to a recent Congressional Research Service review, … Continue Reading

Senators Introduce VENUE Act as Last Stand on Patent Legislation This Congress

As Congress becomes further embroiled in election-year politics, especially a high-stakes standoff between the White House and the Senate Judiciary Committee over the President’s nomination to the Supreme Court, it appears ever more likely that 114th Congress will end in December 2016 without passing comprehensive patent legislation.  With the House and Senate patent bills on … Continue Reading

The Republican Senate Take-Over: Implications for the Affordable Care Act

The mid-term election brings an historic changing of the guard in the health care leadership in Congress.  Republicans will take control of the Senate in January and gain key chairmanships.  Senior Democrats like Senators Harkin and Rockefeller, and Representatives Dingell and Waxman, who have been leaders on health policy issues for decades, are retiring.  Congress … Continue Reading

Managing Political Polarization in Congress

Few can dispute the dysfunction of recent Congresses.  The 112th Congress proved the least productive in modern history as measured by laws passed.  The dramatic federal government funding standoff in the 113th Congress culminated in a 16-day shutdown that drove congressional approval to its lowest level ever.  Yet despite these failures, a close look at … Continue Reading

Developments in Congress on Patent Legislation

Patent legislation has been an issue of intense interest for Congress and industries alike over the past year.  The Chairman of the Senate Judiciary Committee recently took patent legislation off the committee’s agenda in a move that increases the likelihood that Congress will not pass a patent bill this year. Democratic Chairman Patrick Leahy of … Continue Reading
LexBlog